<?xml version="1.0" encoding="UTF-8"?>
<document id="26199132">
	<sentence id="s1" text="We investigated the negative regulation of transcription by RNA polymerase II of the biomarkers of S-G2-M phases of cell cycle, Aurora kinase B (negative regulation of transcription by RNA polymerase II) and geminin (negative regulation of DNA replication), on disease progression in neuroblastomas.">
		<entity id="s1.e1" charOffset="20-77"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<entity id="s1.e2" charOffset="145-202"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<entity id="s1.e3" charOffset="198-212"
			type="HP" text="neuroblastomas" ontology_id="HP_0003006"/>
		<entity id="s1.e4" charOffset="217-255"
			type="GO" text="negative regulation of DNA replication" ontology_id="GO_0008156"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p2" e1="s1.e2"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p3" e1="s1.e4"
		    e2="s1.e3" pgr="false"/>
	</sentence>
	<sentence id="s2" text="The expression of negative regulation of transcription by RNA polymerase II and negative regulation of DNA replication was studied by immunostaining 84 neuroblastomas.">
		<entity id="s2.e1" charOffset="18-75"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<entity id="s2.e2" charOffset="80-118"
			type="GO" text="negative regulation of DNA replication" ontology_id="GO_0008156"/>
		<entity id="s2.e3" charOffset="118-132"
			type="HP" text="neuroblastomas" ontology_id="HP_0003006"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e3" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="false"/>
	</sentence>
	<sentence id="s3" text="The PI for both markers was significantly higher in neuroblastomas from patients with unfavorable clinical (high-risk group, advanced stage, age â‰¥18 months at presentation, primary abdominal compared to extra-abdominal sites), biological (positive regulation of gene expression amplification, 1p deletion, 17q gain), and pathological (undifferentiated or poorly differentiated status, high mitosis-karyorrhexis index, [MKI], unfavorable histology) factors.">
		<entity id="s3.e1" charOffset="52-66"
			type="HP" text="neuroblastomas" ontology_id="HP_0003006"/>
		<entity id="s3.e2" charOffset="239-277"
			type="GO" text="positive regulation of gene expression" ontology_id="GO_0010628"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
	<sentence id="s4" text="Our study shows that in neuroblastomas, negative regulation of transcription by RNA polymerase II- or negative regulation of DNA replication-based PI provides valuable prognostic information and high PI indicates aggressive disease">
		<entity id="s4.e1" charOffset="24-38"
			type="HP" text="neuroblastomas" ontology_id="HP_0003006"/>
		<entity id="s4.e2" charOffset="40-97"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<entity id="s4.e3" charOffset="102-140"
			type="GO" text="negative regulation of DNA replication" ontology_id="GO_0008156"/>
		<pair id="s4.p1" e1="s4.e1"
		    e2="s4.e2" pgr="false"/>
		<pair id="s4.p2" e1="s4.e1"
		    e2="s4.e3" pgr="false"/>
	</sentence>
</document>
